Genetic contribution of the interleukin-10 promoter polymorphism in endometriosis susceptibility

American Journal of Reproductive Immunology

Volumn 47, Issue 1, 2002, Pages 12-18

  Kitawaki, Jo ^a   Obayashi, Hiroshi ^a,b   Ohta, Mitsuhiro ^c   Kado, Noriko ^a   Ishihara, Hiroaki ^a   Koshiba, Hisato ^a   Kusuki, Izumi ^a   Tsukamoto, Katsumi ^a   Hasegawa, Goji ^a   Nakamura, Naoto ^a   Yoshikawa, Toshikazu ^a   Honjo, Hideo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kyoto Microbiological Institute   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Autoantibodies to carbonic anhydrase II; Endometriosis; Interleukin 10; Interleukin 10 gene polymorphisms

Indexed keywords

AUTOANTIBODY; CARBONATE DEHYDRATASE II ANTIBODY; CYTOKINE; INTERLEUKIN 10; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; FEMALE FERTILITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOMODULATION; INCIDENCE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; ALLELES; AUTOANTIBODIES; CARBONIC ANHYDRASE II; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-10; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS);

EID: 0036094950     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0897.2002.1o029.x     Document Type: Article

References (38)

1. Familial endometriosis
2. The familial risk of endometriosis
3. Genetic influences on endometriosis in an Australian twin sample
4. Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population
5. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis
6. Association of estrogen receptor gene polymorphisms with endometriosis
7. Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata
8. Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis
9. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium
10. Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis
11. Is endometriosis an autoimmune disease?
12. Autoimmunity and reproductive failure
13. Peritoneal fluid cell populations in infertility patients
14. Increased activation of pelvic macrophages in infertile women with mild endometriosis
15. Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis
16. Interleukin-10: Biology, role in inflammation and autoimmunity
17. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes
18. An investigation of polymorphism in the interleukin-10 gene promoter
19. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence
20. Genetic influence on cytokine production and fatal meningococcal disease
21. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis
22. Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis
23. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis
24. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis
25. Revised American Fertility Society classification of endometriosis
26. Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Na1 and SDS
27. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
28. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus
29. Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: Implications of diverse effects of IL-10 in the pathogenesis of the disease
30. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus
31. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis
32. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease
33. The pattern of cytokine mRNA expression in ovarian endometriomata
34. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
35. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein
36. Peritoneal and peripheral B-1-cell populations in patients with endometriosis
37. Endometriosis: Identification by carbonic anhydrase autoantibodies and clinical features
38. Antibodies to carbonic anhydrase in endometriosis: Prevalence, specificity, and relationship to clinical and laboratory parameters